ClinicalTrials.gov
ClinicalTrials.gov Menu

Olmutinib (BI 1482694) ADME Study

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02722161
Recruitment Status : Completed
First Posted : March 29, 2016
Last Update Posted : July 13, 2016
Sponsor:
Information provided by (Responsible Party):
Boehringer Ingelheim

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : June 2016
  Actual Study Completion Date : June 2016